Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Hardick

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|August 16, 2019
Structure Defines Function: Clinically Relevant Mutations in ErbB KinasesJanina Niggenaber, Julia Hardick, Jonas Lategahn, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2017
Covalent Lipid Pocket Ligands Targeting p38α MAPK MutantsMike Bührmann, Julia Hardick, Jörn Weisner, et al.
Plos One|September 12, 2017
Structure-based design, synthesis and crystallization of 2-arylquinazolines as lipid pocket ligands of p38α MAPKMike Bührmann, Bianca M Wiedemann, Matthias P Müller, et al.
Journal of Medicinal Chemistry|February 16, 2019
Targeting the MKK7-JNK (Mitogen-Activated Protein Kinase Kinase 7-c-Jun N-Terminal Kinase) Pathway with Covalent InhibitorsPatrik Wolle, Julia Hardick, Shane J F Cronin, et al.
Journal of Medicinal Chemistry|October 10, 2017
Inhibitors to Overcome Secondary Mutations in the Stem Cell Factor Receptor KITHelena Kaitsiotou, Marina Keul, Julia Hardick, et al.
Journal of Medicinal Chemistry|January 22, 2025
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GISTTom Schulz, Rajesh Gontla, Alina Teuber, et al.
Chemical Science|April 19, 2019
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase AktNiklas Uhlenbrock, Steven Smith, Jörn Weisner, et al.
Journal of Medicinal Chemistry|August 1, 2022
Optimization of Covalent MKK7 Inhibitors <i>via</i> Crude Nanomole-Scale LibrariesPaul Gehrtz, Shir Marom, Mike Bührmann, et al.
Journal of Medicinal Chemistry|September 15, 2020
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design ApproachJonas Lategahn, Julia Hardick, Tobias Grabe, et al.
Chemical Science|December 21, 2019
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797SJonas Lategahn, Marina Keul, Philip Klövekorn, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|August 16, 2019
Structure Defines Function: Clinically Relevant Mutations in ErbB KinasesJanina Niggenaber, Julia Hardick, Jonas Lategahn, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2017
Covalent Lipid Pocket Ligands Targeting p38α MAPK MutantsMike Bührmann, Julia Hardick, Jörn Weisner, et al.
Plos One|September 12, 2017
Structure-based design, synthesis and crystallization of 2-arylquinazolines as lipid pocket ligands of p38α MAPKMike Bührmann, Bianca M Wiedemann, Matthias P Müller, et al.
Journal of Medicinal Chemistry|February 16, 2019
Targeting the MKK7-JNK (Mitogen-Activated Protein Kinase Kinase 7-c-Jun N-Terminal Kinase) Pathway with Covalent InhibitorsPatrik Wolle, Julia Hardick, Shane J F Cronin, et al.
Journal of Medicinal Chemistry|October 10, 2017
Inhibitors to Overcome Secondary Mutations in the Stem Cell Factor Receptor KITHelena Kaitsiotou, Marina Keul, Julia Hardick, et al.
Journal of Medicinal Chemistry|January 22, 2025
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GISTTom Schulz, Rajesh Gontla, Alina Teuber, et al.
Chemical Science|April 19, 2019
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase AktNiklas Uhlenbrock, Steven Smith, Jörn Weisner, et al.
Journal of Medicinal Chemistry|August 1, 2022
Optimization of Covalent MKK7 Inhibitors <i>via</i> Crude Nanomole-Scale LibrariesPaul Gehrtz, Shir Marom, Mike Bührmann, et al.
Journal of Medicinal Chemistry|September 15, 2020
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design ApproachJonas Lategahn, Julia Hardick, Tobias Grabe, et al.
Chemical Science|December 21, 2019
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797SJonas Lategahn, Marina Keul, Philip Klövekorn, et al.
Pageof 2